Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
2021 · Kidney International · 726 citations
https://doi.org/10.1016/j.kint.2021.05.015
K
Keisha L. Gibson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
162
Papers
7.5K
Citations
33
h-index
63
i10-index
Keisha L. Gibson is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Renal Diseases and Glomerulopathies & Chronic Kidney Disease and Diabetes & Systemic Lupus Erythematosus Research. The author has an h-index of 33, co-authored 138 publications.
ORCID: 0000-0003-4702-8150Papers by this author
worksEfficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
2021 · The Lancet · 534 citations
https://doi.org/10.1016/s0140-6736(21)00578-x
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
2019 · Kidney International · 257 citations
https://doi.org/10.1016/j.kint.2018.10.018
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
2022 · Pediatric Nephrology · 231 citations
https://doi.org/10.1007/s00467-022-05739-3
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
2019 · Kidney International · 183 citations
https://doi.org/10.1016/j.kint.2018.11.008
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease
2018 · American Journal of Kidney Diseases · 131 citations
https://doi.org/10.1053/j.ajkd.2018.07.020
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat